61
Participants
Start Date
December 31, 2015
Primary Completion Date
February 20, 2017
Study Completion Date
September 27, 2017
Presatovir
Tablets administered orally or via nasogastric (NG) tube once daily
Placebo
Tablets administered orally or via NG tube once daily
Phoenix
Los Angeles
San Francisco
Stanford
Tampa
Atlanta
Chicago
Maywood
New Orleans
Boston
Ann Arbor
Cleveland
Philadelphia
Pittsburgh
Dallas
San Antonio
Seattle
Sydney
Brisbane
Murdoch
Brussels
Yvoir
Toronto
Strasbourg
Hanover
Munich
Rotterdam
Cambridge
Lead Sponsor
Gilead Sciences
INDUSTRY